Dementia and Dementia Care

Neuroimaging and Biomarkers

Neuroimaging:

Neuroimaging encompasses a variety of techniques that visualize the structure and function of the brain. These techniques are used to diagnose brain diseases, monitor brain health, and guide treatment strategies.

Key Techniques:

Magnetic Resonance Imaging (MRI):

• Structural MRI: Provides high-resolution images of brain anatomy, useful for identifying structural abnormalities such as tumors, brain injuries, and neurodegenerative diseases.
• Functional MRI (fMRI): Measures brain activity by detecting changes in blood flow, often used in research to understand brain function and in clinical settings to locate brain regions involved in specific functions.

Biomarkers:

Biomarkers are measurable indicators of biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. In neurology and psychiatry, biomarkers can provide valuable information about the presence, risk, progression, or response to treatment of neurological and psychiatric conditions.

Types of Biomarkers:

1. Genetic Biomarkers:
   • Variations in DNA that are associated with the risk of developing certain neurological conditions, such as the APOE gene variant linked to Alzheimer’s disease.
2. Proteomic Biomarkers:
   • Proteins or peptides measured in blood, cerebrospinal fluid (CSF), or other tissues that reflect disease processes, such as amyloid-beta and tau proteins in Alzheimer’s disease.